Infective Endocarditis

Infective endocarditis is an infection involving the inner lining of the heart, usually affecting a native or prosthetic valve or an implanted cardiac device. It can damage valves and cause heart failure, stroke, abscess or infection in other organs.

Recognition and Diagnosis

Persistent fever, chills, night sweats, unexplained fatigue, weight loss, breathlessness or new neurological symptoms may occur. Risk is higher with prosthetic valves, previous endocarditis, certain congenital heart conditions and some cardiac devices. Diagnosis relies on blood cultures collected before antibiotics when the patient is stable, together with echocardiography and other imaging when needed.

Treatment

Treatment usually requires prolonged intravenous antibiotics selected for the identified organism. Early discussion by an endocarditis team is important when there is heart failure, uncontrolled infection, abscess, prosthetic material or recurrent embolism. Some patients require valve or device surgery.

Antibiotic prophylaxis is reserved for selected high-risk patients undergoing specified procedures; meticulous oral hygiene remains fundamental.

Clinical Depth and Risk Assessment

Risk is not defined by the diagnostic label alone. Symptoms, ECG and rhythm findings, ventricular function, myocardial scar or structural change, family history, associated disease and previous events are integrated. Genetic results, when relevant, require expert interpretation; a variant of uncertain significance is not equivalent to a diagnosis.

Diagnostic Strategy and Limitations

Testing is selected to answer a specific question. ECG, ambulatory monitoring, echocardiography, cardiac MRI, CT, laboratory testing, exercise assessment or invasive evaluation have complementary roles. A normal test may not exclude an intermittent disorder, while an abnormal measurement must be checked against technical quality and clinical probability.

Treatment Decision Framework

Treatment may combine risk-factor control, condition-specific medicines, rhythm or heart-failure therapy, catheter procedures, surgery and implanted devices. These options address different mechanisms and are not automatically substitutes for one another. Expected benefit, uncertainty, procedural burden and the patient’s informed preferences should be discussed explicitly.

Long-Term Follow-up

Follow-up assesses symptoms, exercise capacity, rhythm burden, ventricular function and treatment tolerance over time. Family screening may be appropriate in inherited or suspected inherited disease. New fainting, sustained rapid rhythm, chest pain, neurological symptoms or rapidly worsening breathlessness requires urgent assessment.

Questions to Discuss With the Cardiology Team

• Which finding has the greatest influence on my present risk?
• Which test or treatment would genuinely change management?
• What symptoms should lead to an earlier appointment or emergency care?
• Do relatives need clinical or genetic assessment?

Medical Information Note

This page supports an informed discussion with the clinical team. It does not provide a personal diagnosis, medicine dose or sports-clearance decision.